Canagliflozin Beneficial Even for Advanced Kidney Disease
Canagliflozin slows progression of kidney disease in participants with eGFR <30 mL/min/1.73 m2 with no increase in AKI
All articles by Haymarket Media
Hormonal Contraceptives Linked to Decline in Asthma Exacerbation
Risk reduced with previous and current use of any and combined hormonal contraceptives, not with progestogen-only use
USPSTF Urges Behavioral Counseling to Reduce CVD Risk
Behavioral counseling interventions to promote healthy diet and physical activity have moderate net benefit
RSNA: Neurologic Complications of COVID-19 Examined
In patients with critical findings identified on neuroimaging, most common comorbidities were hypertension, diabetes
BCG Vaccination Linked to Lower SARS-CoV-2 Seroprevalence
Seroprevalence of anti-SARS-CoV-2 IgG lower for health care workers with history of BCG vaccination
ATS Issues Guideline on Home Oxygen Therapy for COPD, ILD
Long-term oxygen therapy strongly recommended for adults with COPD, ILD who have severe chronic resting hypoxemia
WHO: Remdesivir Not Advised for Hospitalized COVID-19 Patients
Evidence to date has not shown clinically important effects on mortality, need for mechanical ventilation
Disproportionality Signal Found for Suicidality in Finasteride Users
Younger patients and those with alopecia have significant disproportionality signals for increased suicidality
Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib
Hormonal Contraceptive Use May Delay Return of Fecundability
Longest delay of five to eight months found for users of injectable contraceptives; no lasting effect seen on fecundability for long-term use
